European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Intendis GmbH, Schönefeld, Germany✝︎

Watch
Intendis GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Intendis GmbH
Berlax 01 GmbH

Identification

Ut
District Court of Charlottenburg (Berlin) HRB 79750 B
Lei
52990086PLF2ZISA0R09
EUID
DEF1103R.HRB79750B

Address

Schönefeld, Germany
Berlin, Germany

Corporate purpose

Die Forschung und Entwicklung, Produktion, Vermarktung und der Vertrieb von topischen und systemischen Arzneimitteln zur Behandlung von Hauterkrankungen.

History

Persons

Marketing & Tech

Merger & Acquisition & Control

Network

Loading network

Legal Structure

Last legal representatives Legal form information Premium
Premium
4Managing Director
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
tax haven banner

Publications

28 Sept 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
3 Sept 2020
Ter­mi­na­tion
4 Aug 2020
Merger: LEO Pharma A/S
4 Jun 2020
Annual report for the year ending 31/05/2019 · Balance sheet for 31/05/2019 · Earnings statement for 31/05/2019 · 3 Shareholdings: Bayer Pharma AG, Intraserv GmbH & Co.KG, Intraserv Verwaltungs-GmbH
3 Jun 2020 via Intraserv Verwaltungs-GmbH also 26/05/2020
Merger: Intraserv Verwaltungs-GmbH
27 May 2020
Merger: Intraserv Verwaltungs-GmbH
14 May 2020
Vorgänge ohne Eintragung vom 14.05.2020
19 Nov 2019
No longer Authorized signatory (ppa) (1)
25 Jul 2019
No longer Authorized signatory (ppa) (1)
11 Jul 2019
Managing Director: Daniela Chuayre
11 Jul 2019
Zur Eintragung laufende Nr. 38 wird als nicht eingetragen veröffentlicht: Der andere Vertragsteil hat den Gläubigern…
27 Jun 2019
Share­holder agreement
17 Jun 2019
Rechtsverhaeltnis: Der mit der Bayer Pharma AG bestehende Beherrschungsvertrag ist durch Aufhebungsvereinbarung vom…
17 Jun 2019
Als nicht eingetragen wird veröffentlicht: Der andere Vertragsteil hat den Gläubigern dieses Rechtsträgers, deren…
22 May 2019 via Bayer AG also 25/04/2018, 16/04/2018, 17/05/2017, 22/04/2016, 21/04/2015, 05/05/2014, 17/05/2013, 23/04/2012, 27/04/2011, 14/04/2010, 08/05/2009
Shareholder: Bayer AG
20 May 2019
Änderung zu Nr. 9: hinsichtlich der Vertretungsmacht, nunmehr; Geschäftsführer: Bergmann, Ulrich; mit der Befugnis die…
8 May 2019
Patent: Hydrogel Composition for the Treatment of Dermatological Disorders
23 Apr 2019
Managing Director: Ulrich Bergmann, Daniela Chuayre · No longer Managing Director: Thomas Bögner, Burkhard Stoy · Authorized signatory (ppa) (2)
15 Apr 2019
Managing Director: Ulrich Bergmann, Daniela Chuayre · No longer Managing Director: Thomas Bögner, Burkhard Stoy · Authorized signatory (ppa) (2)
5 Apr 2019
Share­holder agreement
28 Feb 2019
Seat: Die Eintragung betreffend die Geschäftsanschrift ist von Amts wegen wie folgt berichtigt: Geschäftsanschrift: Mittelstraße 5/5a
18 Feb 2019
Address
17 Dec 2018
Authorized signatory (ppa) (1)
17 Dec 2018
Authorized signatory (ppa) (1)
17 Jan 2018 via Bayer Pharma AG also 28/12/2016, 05/02/2016, 14/01/2015, 31/12/2013
Shareholder: Bayer Pharma AG
19 Jul 2017
Patent: Anhydrous Multiphase GEL System
21 Jun 2017
Managing Director: Thomas Bögner
6 Apr 2017
Patent: Zusammensetzung mit Azelainsäure
15 Mar 2017
Patent: USE of a Foamable Composition Essentially Free of Pharmaceutically Active Ingredients for the Treatment of Human Skin
13 Oct 2016
No longer Managing Director: Alexander Henrici
20 Jan 2015
Address
17 Dec 2014
Patent: Anhydrous Multiphase gel System
15 Jan 2014
No longer Authorized signatory (ppa) (3) · Managing Director (2) · Control: Bayer Pharma AG
9 Dec 2013
No longer Authorized signatory (ppa) (3) · Authorized signatory (ppa) (1)
1 Feb 2013
Managing Director: Alexander Henrici · No longer Authorized signatory (ppa): Alexander Henrici · No longer Managing Director (1)
26 Nov 2012
Authorized signatory (ppa) (1)
13 Mar 2012
No longer Authorized signatory (ppa) (1)
14 Nov 2011
Profit Transfer: Bayer Pharma AG
9 Nov 2011
No longer Authorized signatory (ppa) (1)
18 Oct 2011
Authorized signatory (ppa) (1)
16 Jun 2011
Legal form: U.A
27 May 2011
Patent: Formulation Containing Azelaic Acid and Having a Pigment Addition
20 May 2011
Authorized signatory (ppa): Daniela Chuayre
9 Mar 2011
Patent: Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
28 Feb 2011
Patent: Medicine packaging with viewing window
6 Aug 2010
No longer Authorized signatory (ppa) (1)
22 Jul 2010
Authorized signatory (ppa) (1)
1 Jul 2010
Patent: Hydrogelzusammensetzung zur Behandlung von Dermatologischen Erkrankungen
1 Jul 2010
Patent: Verwendung einer von Pharmazeutischen Wirkstoffen im Wesentlichen Freien Schäumbaren Zusammensetzung für die Behandlung von Menschlicher Haut
1 Jul 2010
Patent: Verwendung einer von Pharmazeutischen Wirkstoffen im Wesentlichen Freien Schäumbaren Zusammensetzung für die Behandlung von Menschlicher Haut
10 Feb 2010
No longer Authorized signatory (ppa) (1)
22 Dec 2009
Patent
21 Dec 2009
Managing Director (1) · Profit Transfer: Bayer Schering Pharma AG · Control: Bayer Schering Pharma AG
9 Sept 2009
Authorized signatory (ppa) (7)
28 Aug 2009 via Intendis Polska sp. z o.o. also 12/12/2006, 22/09/2005
Shareholding: Intendis Polska sp. z o.o
30 Jun 2009 via Intendis Dermatologie GmbH
Merger: Intendis Dermatologie GmbH
30 Jun 2009
Merger: Intendis Dermatologie GmbH
15 May 2009
No longer Managing Director (1)
Year 2008 in Epobase
4 European patent filings: Hydrogel Composition for the Treatment of Dermatological Disorders …
18 Dec 2008
Managing Director (1) · Address
7 Apr 2008 via Bayer Pharma AG also 07/04/2008, 08/08/2007
Shareholder: Bayer Schering Pharma AG
16 Jan 2008
No longer Authorized signatory (ppa) (1)
28 Nov 2007
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · 12 Shareholdings (12 companies)
Year 2007 in Epobase
5 European patent filings: Composition Consisting of Alkane Dicarboxylic Acids and a Pharmaceutically Active Ingredient …
8 May 2007
Managing Director (1) · No longer Managing Director (1)
4 Oct 2006
Patent: Water-Free Skin Care Formulations Comprising Micronized Urea and Method of Manufacturing the Same
29 Mar 2006
Share­holder agreement
2 Jun 2005
Profit Transfer: Schering AG
17 Mar 2005
Capital: €50,000 · Share­holder agreement · Corporate Purpose
28 Jan 2005
Managing Director (1)
18 Jan 2005
Authorized signatory (ppa) (1)
7 Oct 2004
Share­holder agreement · Name: Intendis GmbH
16 Sept 2004
No longer Authorized signatory (ppa) (2) · Managing Director (2) · No longer Managing Director (2) · Share­holder agreement · Corporate Purpose
25 Aug 2004 as Berlax 01 GmbH
Reg­is­tra­tion · Managing Director (2) · ppa (2) · Profit Transfer: Schering AG · Capital: €25,000 · Share­holder agreement · Seat: Berlin, Germany · Name: Berlax 01 GmbH · Corporate Purpose
There are no publications matching your search.

Mentions

15 Jun 2020 in Ler
No longer Direct parent
15 Jun 2020 in Ler
No longer Ultimate parent
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.